NCT00117143
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
- Locations
-
Not specified
Clinical trial condition
Cytopenia
Explore clinical trials studying Cytopenia. Study availability and eligibility vary by location and protocol.
1,007 public trials
191 recruiting studies
Cytopenia trial results
NCT05889169
- Conditions
- Brain Diseases, Cardiovascular Diseases, Central Nervous System Diseases, +14 more
- Locations
-
- Headache Science & Neurorehabilitation Center Pavia, Italy
NCT03275454
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +15 more
- Locations
-
- Georgetown Lombardi Comprehensive Cancer Center Georgetown, District of Columbia, United States
- Massachusetts General Hospital - Cancer Center Boston, Massachusetts, United States
- University of Pittsburgh Medical Center (UPMC) Hilman Cancer Center Pittsburgh, Pennsylvania, United States
- Essen University Hospital Department of Hematology Essen, Germany
NCT00937131
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Cytopenia, +14 more
- Locations
-
- St Bartholomew's Hospital London, United Kingdom
- St Thomas Hosptial London, United Kingdom
- University College London Hospitals London, United Kingdom
NCT03801122
- Conditions
- Blood Platelet Disorders, Cytopenia, Hematologic Diseases, +9 more
- Locations
-
- CHU de Saint-Etienne Saint-Etienne, France
NCT00713193
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Cytopenia, +16 more
- Locations
-
- Ohio State University Columbus, Ohio, United States
NCT01891994
- Conditions
- Agranulocytosis, Anemia, Anemia, Aplastic, +13 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT03394755
- Conditions
- Anemia, Anemia, Aplastic, Blood Platelet Disorders, +10 more
- Locations
-
- City of Hope Duarte, California, United States
- Georgetown University Hospital Washington D.C., District of Columbia, United States
- University of Michigan Ann Arbor, Michigan, United States
- Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States
Completed
Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura
NCT02553317
- Conditions
- Acquired Thrombotic Thrombocytopenic Purpura, Blood Coagulation Disorders, Blood Platelet Disorders, +14 more
- Locations
-
- Investigator Site Birmingham, Alabama, United States
- Investigator Site Los Angeles, California, United States
- Investigator Site Atlanta, Georgia, United States
- Investigator Site Boston, Massachusetts, United States
NCT01151423
- Conditions
- Acquired Thrombotic Thrombocytopenic Purpura, Blood Coagulation Disorders, Blood Platelet Disorders, +14 more
- Locations
-
- Investigator Site Los Angeles, California, United States
- Investigator Site Washington D.C., District of Columbia, United States
- Investigator Site Atlanta, Georgia, United States
- Investigator Site St Louis, Missouri, United States